Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline